| ABBOTT LABORATORIES |
| USA |
| Gesundheit |
| US0028241000 / 850103 |
| ABL (Frankfurt) / ABT (NYSE) |
| FRA:ABL, ETR:ABL, ABL:GR, NYSE:ABT |
| S&P500 |
| https://www.abbott.com/ |
|
Abbott Laboratories is a diversified healthcare company that discovers, develops, manufactures, and sells a comprehensive range of medical products and pharmaceuticals globally. The company operates through four primary segments: Established Pharmace..
>Volltext.. |
| 145279.84 Mio. EUR |
| 168978.83 Mio. EUR |
| 39460.21 Mio. EUR |
| 9778.94 Mio. EUR |
| 5487.92 Mio. EUR |
| 3.15 EUR |
| 29766.96 Mio. EUR |
| 5947.8 Mio. EUR |
| 8274.28 Mio. EUR |
| 0.4 |
| -0.19% |
| -56.24% |
| 2.09 EUR |
| 2.56% |
| 2.64% |
| 15.04.26 - 0.53442895€ 15.01.26 - 0.542178€ >weitere anzeigen... |
| ABBOTT LABORATORIES, ABBOTT LABS, ABBOTT LAB, (ABT), ABT |
| 05.07.26 |
|